We spoke to Professor Tabassome Simon (Hospital Saint-Antoine, Paris, France) on the background, aims and design of the REALITY study (REstrictive And LIberal Transfusion strategies in patients with acute mYocardial infarction and anemia; ClinicalTrials.gov identifier NCT02648113), as well as the findings of the study to date.
- How prevalent is anaemia in patients with myocardial infarction and what are its prognostic implications? (0:21)
- Why is there a lack of consensus about which transfusion strategy is best in these patients? (1:15)
- Could you give us an overview of the aims and designs of the REALITY study? (2:52)
- What have been the findings of the study to date? (5:27)
- What are the clinical implications of these findings and what future studies are planned? (9:33)
Speaker disclosures: Professor Tabassome Simon has nothing to declare in relation to this video interview.
Commissioned, edited and funded by Touch Medical Media.
Filmed during a remote video call with Professor Tabassome Simon, September 2020.
Share this Video
Related Videos In Interventional Cardiology
Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Gregg Stone, ACC 2023: COAPT trial results – Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview Dr Gregg Stone (Mount Sinai Heart Health System, New York City, NY, USA) discusses the […]
Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient’s clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea) to discuss the current guidelines for the […]